Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy. Andersson NW, Zachariae C, Simonsen AB. Eur J Cancer 2021;145:168-170.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Andersson NW, Zachariae C, Simonsen AB. Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy. Eur J Cancer 2021;145:168-170.
PMID: 33486439